Connect with us


Trending Penny Stocks to Buy Now? 5 to Watch This Week

Which trending penny stocks are on your watchlist right now?
The post Trending Penny Stocks to Buy Now? 5 to Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information |



5 Trending Penny Stocks to Add to Your Watchlist Right Now 

After a volatile and exciting week of trading penny stocks, investors show bullish sentiment in the stock market. Last week, we witnessed record highs with the S&P 500 and Bitcoin, both illustrating just how much positivity there is in the stock market right now. 

But, we are also experiencing an unprecedented level of volatility that has led to large intraday swings in both directions. You’ve also got external factors like extremely bullish buying spikes moves in small-cap stocks like newly-dubbed “Trump Stock,” Digital World Acquisition Corp. (NASDAQ:DWAC). This 1,000+% move last week ultimately woke up the broader small-cap space and we saw countless penny stocks surging into the close of the week. Looking ahead we can monitor what else is going on in the world to understand where the opportunity might be heading into the final week of October. 

For example, after Bitcoin hit a record high of over $67000 on platforms like Robinhood, we witnessed many crypto and blockchain penny stocks climb substantially in value. This is a more obvious example and a perfect display of cause and effect.

Read more: 6 Best Penny Stocks To Watch As Bitcoin Price Hits All-Time High

With penny stocks, we tend to see speculation play a more prominent role than with blue chips. This is due to their low price, high volatility, and willingness to shift in price. But, this means that investors need to stay as up-to-date as possible on everything going on with the stocks they’re interested in. 

In addition to looking at company-specific news, traders need to understand what is occurring in the industry at large. All of this will provide traders with a solid backbone on which they can invest. Considering all of this, let’s take a look at five trending penny stocks to add to your watchlist right now. 

Trending Penny Stocks To Buy [or avoid] 

  1. Kosmos Energy Ltd. (NYSE: KOS)
  2. Cyclerion Therapeutics Inc. (NASDAQ: CYCN)
  3. Gaotu Techedu Inc. (NYSE: GOTU)
  4. Color Star Technology Co., Ltd. (NASDAQ:CSCW)
  5. Inpixon (NASDAQ:INPX)

Kosmos Energy Ltd. (NYSE: KOS)

Kosmos Energy Ltd. is an oil and gas company focused on deepwater exploration. The company actively searches along the Atlantic Margins in places like offshore Ghana, Equatorial Guinea, and the U.S. Gulf of Mexico. Kosmos also owns a gas development offshore property in Mauritania and Senegal. In addition to all of this, Kosmos has a proven basin exploration program that is currently operational.

[Read More] Penny Stocks To Buy Today? 3 To Watch After Trump Media DWAC Jumps

On October 13th, the company acquired an additional 18% interest in the Jubilee field and an additional 11% interest in the TEN fields in Ghana from Occidental Petroleum. The total purchase price of the other interests was $550 million. These acquired assets significantly enhance Kosmos’ five-year plan. The company expects these additional Ghana interests to generate about $1 billion of incremental free cash flow by the end of 2026.

“This is a compelling transaction for Kosmos that accelerates our strategic delivery and is expected to provide long-term sustainable cash flow from fields where we have a deep understanding of the value and future upside.”

CEO and Chairman of Kosmos, Andrew G. Inglis

Since this announcement was made, KOS stock has gone up substantially in the market. Its volume is also higher than its average over the past few trading days. Keeping this in mind, will KOS be on your list of penny stocks to watch?

Cyclerion Therapeutics Inc. (NASDAQ: CYCN)

Cyclerion Therapeutics Inc. is a biotech penny stock that has been climbing in several recent trading sessions. This company creates medicines for serious central nervous system diseases. Cyclerion is involved in the discovery, development, and commercialization of these products. One of its products is CY6463 which is in Phase 2 trials to treat mitochondrial encephalomyopathy, stroke-like episodes, and more.

[Read More] 4 Hot Penny Stocks To Watch After The 1,282% HX Stock Rally

On September 22nd, the company announced a publication demonstrating that the administration of a small molecule soluble guanylate cyclase simulator was effective. It reduced markers associated with neuroinflammation in multiple preclinical models. Neuroinflammation is a big part of various diseases such as Alzheimer’s and other neurodegenerative disorders.

“A body of preclinical and clinical data supports the development of CY6463 and CY3018, our brain-penetrant sGC stimulators, and administration of CY6463 has been shown to result in positive clinical effects on multiple measures of brain neurophysiology.”

Study Author and Head of Translational Medicine at Cylerion, Chris Winrow

In the past few days, CYCN’s volume has been almost four times its market average. This is a clear indicator of its trending nature and how popular CYCN stock is right now. With this in mind, will CYCN make your list of penny stocks to watch?


Gaotu Techedu Inc. (NYSE: GOTU)

Gaotu Techedu Inc. is one of several Chinese educational stocks moving in the last week or so. For some context, Gaotu offers K-12 after-school tutoring services in the country. These K-12 services include math, English, chemistry, biology, Chinese, and more. It also provides foreign language courses, professional courses, English test prep services, and qualification exams.

On September 21st, the company released its second-quarter financial results for 2021. During this period, its revenue increased by 35.3% year over year to a total of RMB2,232.3 million. Its gross billings went up 12.2% year over year to RMB2,694.7 million as well. In addition to all of this, Gaotu’s paid course enrollments totaled 4.1% higher year over year.

“We say that 2014 is Gaotu’s first attempt as a startup, and 2016 is our second start, then we can also say that 2021 is our third start. We should always keep the goal of education in mind, always firmly believe that education is a noble profession. It’s undeniable that we have boundless faith in the bright future of the Chinese education industry.”

The CEO, Founder, and Chairman of Gaotu, Larry Xiangdong Chen

Over the past week, we’ve seen several days with GOTU stock moving up in the double-digit percentage points. With this to note, is GOTU on your penny stock watchlist right now?


Color Star Technology Co., Ltd (NASDAQ:CSCW)

Tech penny stocks have certainly been something that traders are zeroing in on this quarter. The broader sector, as a whole, is strongly rebounding into year-end. Everything from information technology to entertainment has benefited. In the case of Color Star Technology, its entertainment-focused model continues attracting attention in the stock market.

Read more: Best Penny Stocks To Buy Now? 3 To Watch At The End Of October

Most recently, a focus on artificial intelligence and its involvement in tech is what Color Star is working on. In particular, it’s building a metaverse project that encompasses everything from virtual reality entertainment like concerts and an active platform for non-fungible tokens (NFTs) related to simulation scenes. There are also layers to the metaverse project, including shopping. Via the company’s Color Star app, users can access entertainment, social networking, virtual gaming, and even interact with celebrities virtually with their avatars in the metaverse.

With immersive experiences becoming a more significant point of interest since the pandemic, companies like Color Star are working on blending online life with offline reality leveraging entertainment as the pathway to do so.

trending penny stocks to buy avoid this week Color Star Technologies CSCW stock chart


Sticking with the focus on augmented and virtual reality stocks, Inpixon has gained some interest over the weekend. The company specializes in its Indoor Intelligence platform. It has effectively been used for mapping, positioning, and helping create smart & secure environments. While its location awareness technology has helped extend its reach in government-related settings, a recent development could have given a boost when it comes to civilian applications.

Last week Inpixon announced a new initiative along with Ostendo Technology, Inc., a company developing quantum photonics and micro-display technologies. In addition to a current Strategic Collaboration and Cross-Marketing Agreement, the two companies will provide the City of Miami Beach’s Washington Avenue Business Improvement District with an augmented-reality-enabled mobile ‘ExperienceApp.’

This app also supports the integrated use of Ostendo’s AR smart glasses for an initial period of two years. According to Nadir Ali, CEO of Inpixon, “Inpixon’s ExperienceApp will be built on our CXApp mobile app platform and will incorporate mapping, positioning, analytics, and AR to deliver an exceptional user experience that is productive, intelligent, easy to use, and will be viewed through Ostendo AR smart glasses.”

With a surge of post-market action on Friday, it will be interesting to see how INPX stock begins the upcoming week.

trending penny stocks to buy avoid this week Inpixon INPX stock chart

Can Penny Stocks Continue to Climb This Year?

Although there is a lot of momentum in the stock market, investors need to choose wisely to have the best chance at making money with penny stocks. And, with this momentum, investors should also understand the root cause and how to use that to their advantage. 

[Read More] Top Penny Stocks to Buy Next Month? Check These 3 Out For Your List

Considering that several factors are impacting blue chips and penny stocks right now, it’s best to break it down individually and focus on one area of the market at a time. Considering this, do you think that penny stocks can continue to climb this year?

The post Trending Penny Stocks to Buy Now? 5 to Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information |

Read More

Continue Reading


Life Sciences Expansions Take Off as 2021 Wraps Up

Several life sciences companies and life science-focused real estate firms announced expansion plans as 2021 comes to an end.



Life Sciences Expansions Take Off as 2021 Wraps Up

Several life sciences companies and life science-focused real estate firms have announced expansion plans as 2021 comes to an end. Here’s a look.

Novavax to Expand Maryland Campus

Novavax, on the cusp of getting its COVID-19 vaccine authorized in numerous countries around the world, is expanding its footprint in Gaithersburg, Md., where it is headquartered. The European Medicines Agency (EMA) is expected to authorize the company’s vaccine soon, and so is the U.S. Food and Drug Administration (FDA). Czechia has already ordered 370,000 doses, with deliveries expected at the beginning of 2022. The company also has a deal with Fujifilm Diosynth Biotechnologies to manufacture millions of doses of the Novavax vaccines at its facilities in Billingham, U.K., with a £400 million investment in expansion.

Four Corners Acquired 150,000-Square-Foot Complex in Belmont, Calif.

Four Corners Properties acquired a 150,000-square-foot office building in Belmont, Calif., called the Shoreway Innovation Center. The seller was Westlake Group. Westlake bought it in 2016 for $61 million. The company plans to expand its use for life sciences, noting that 82% of it is currently leased to a mix of tenants with an average of less than three years lease term remaining.

“Shoreway Innovation Center offers the opportunity to bring office and life sciences space to a market where tenant demand is far outpacing available supply,” said Mike Taquino, executive vice president of CBRE’s Northern California Capital Markets team.

Genentech Leases Building Under Construction in South San Francisco

Source: BioSpace

Boston Properties and Alexandria Real Estate Equities are leasing a building under construction in South San Francisco to Genentech. It will be the first phase of a life sciences campus. The building is at 751 Gateway and is 229,000 square feet. The campus will be called Gateway Commons and is a joint venture between the two real estate firms. They expect initial occupancy toward the end of 2024. Genentech has been headquartered in South San Francisco for forty years, with a large corporate headquarters made up of 4.7 million square feet of five neighborhood hubs. The new site is about one mile’s distance from their main campus.

Mispro Biotech to Open New Facility in North Carolina in Early 2022

Mispro Biotech Services plans to open a new facility in Research Triangle Park (RTP), N.C., in early 2022. Mispro is a leading contract vivarium organization (CVO). The new facility, a full-service vivarium research facility, will be central to one of RTP’s biopark campuses.

“Since we first opened our doors here in 2013, we have seen incredible growth in the RTP cluster,” said Philippe Lamarre, chief executive officer of Mispro. “The time was right to expand into a new facility with more space and modern amenities where we can support the influx of biotechs who are seeking in vivo lab space.”

Laura Gunter, president of NCBIO, representing the life sciences industry in North Carolina, noted, “Mispro has become a cornerstone of the Triangle ecosystem as contract research and support companies are finding increased favor. Biotechs of all sizes and therapeutic disciplines are focusing more on their core competencies, which is opening the door to innovation like Mispro’s contract vivarium option. We are pleased to see their decision to expand here and support more North Carolina companies.”

BioSpace source:

Read More

Continue Reading


Markets stay booster’ed

Equities rally continues US markets managed to maintain omicron is weak, buy everything rally overnight, albeit at a much less frenzied pace than the day before. That sits nicely with my V for Volatility outlook for December and readers should not be…



Equities rally continues

US markets managed to maintain omicron is weak, buy everything rally overnight, albeit at a much less frenzied pace than the day before. That sits nicely with my V for Volatility outlook for December and readers should not be fooled into thinking the risks of whipsaw price have now disappeared. I’ll say it again, volatility will be the winner in December, not directional plays.

Having said that, I am not calling for the end of days for the 21-month stock market rally, merely that we can now expect a lot more two-way volatility going forward. A case in point is the Nasdaq, which has once again bounced off its mighty March 2020 trendline support and will probably be a classical technical analysis case study for years to come. Here’s what CFD from OANDA looks like, the actual physical chart is even sexier, and I’ll leave readers to draw the lines on that one themselves.


Another sign that we may need to wait for next week’s FOMC meeting to climb aboard the taper trade again comes from currency and bond markets. The Australian dollar, the risk sentiment indicator to rule them all, rallied powerfully overnight. Even the euro managed to recover, and the US dollar generally had a tough day at the office. That came as US 10-year yields rose back above 1.50% to 1.53%.

The divergence in price action is a warning sign for tomorrow night’s US CPI. It suggests that the street is positioned for a “risk-off” taper move. With the US 10-year rising around 20 basis points over the last few sessions, reversing recent losses, there may not be much juice in the tank at a 7.0% CPI print. Quid pro quo, US dollar selling and equity buying hint that a 7.0% CPI is increasingly priced in. We likely need to see a print much higher than 7.0% to revive the taper trade in the near term and it wouldn’t surprise me if an on-expectation CPI release sees US yields fall, the US dollar fall, and equities jump once again. Remember what I said about V for Volatility and whipsaw price action?

Helping things along, although with a gentler market impact, were comments from Pfizer and Moderna suggesting a third shoot would do the job against omicron. Given that the US and Europe can’t even get 65% of their populations to have even two shots, let alone a third, we can assume two things. Omicron will yet have a role to play in surging cases over the winter, and vaccine hoarding by rich countries will continue until 35% of their populations stop taking advice from social media and saying me, me, me, instead of we, we, we. That means that the poor in the rest of the world will be waiting longer, thus allowing a higher chance of more nasty variants to arise. And thus, the cycle continues, sigh…

Today’s data calendar in Asia is thin. New Zealand Manufacturing Sales in Q3 fell a dismal 6.20%, suffering from the Auckland Covid lockdown hangover. You can’t buy anything in New Zealand these days anyway; it’s either too expensive thanks to the RBNZ, or there’s none of it left thanks to Covid-19. The New Zealand dollar continues to underperform its Australian cousin, thanks to being another 2,250 kilometers (1,400 statute miles for non-decimal dinosaurs) east of Australia, and the RBNZ hitting the W for Wimp button at its last policy meeting.

On a brighter note, Japan’s Large Manufacturing Index QoQ for Q4 outperformed, rising by 7.90%. Some Q3 baseline effects are in there, but overall, it bodes well for next week’s Tankan survey and suggests that Japan is recovering after it Q3 delta wave. Services may have a more difficult time as the country shut its borders to Johnny Foreigner again this month.

China’s Inflation data has proved benign as well, giving regional markets a small sigh of relief. YoY Inflation for November rose to 2.30% (2.50% exp), while MoM Inflation rose by 0.40% (0.70% exp), giving markets a nil-all draw. That should provide more relief to local equity markets which despite the bad news pouring in from the property developer space this week, is taking their pleas for debt restructuring as meaning the government will facilitate “something.” At least Kaisa suspended trading of their stock in Hong Kong, I’m surprised Evergrande still is. A debt restructuring is not usually good for stock prices, even if they have already fallen by 90%.

The rest of the day’s calendar globally is second-tier. Some regional inflation measures from Europe and Germany’s Balance of Trade. The focus will be on US Initial Jobless Claim with markets hoping for sub-200k prints to resume. Overnight, US Jolts Job Openings for October jumped to 11 million unfilled jobs. That doesn’t really compute with US Non-Farms falling to 210,000, or even a Household Survey suggesting 1.1 million jobs, or unemployment falling to 4.20% with a 61.80% participation rate.

The Federal Reserve may have shot itself in the foot with its unlimited free money we’ll backstop the dumbest investment decisions monetary stimulus which should have been a short term “shock and awe,” and not a monetary Vietnam. Macroeconomics is a beautiful thing when the orchestra all plays in tune, but too often, sticking your finger in one leak sees another pop up nearby. By enriching substantially, any American who owns a home, crypto, a meme or any other stock, they have created a situation where people don’t have to go back to work or have retired. The inflation trade may waver this week, but don’t put it to bed just yet. If James Bond can return from his most diverse and politically correct movie ever (the end credits said he would), inflation sure can as well.

Read More

Continue Reading


Over 170 companies delisted from major U.S. stock exchanges in 12 months

  Over the years, United States-based exchanges have remained an attractive destination for most companies aiming to go public. With businesses jostling to join the trading platforms, the exchanges have also delisted a significant number of companies….





Over the years, United States-based exchanges have remained an attractive destination for most companies aiming to go public. With businesses jostling to join the trading platforms, the exchanges have also delisted a significant number of companies.

According to data acquired by Finbold, a total of 179 companies have been delisted from the major United States exchanges between 2020 and 2021. In 2021, the number of companies on Nasdaq and the New York Stock Exchange (NYSE) stands at 6,000, dropping 2.89% from last year’s figure of 6,179. In 2019, the listed companies stood at 5,454.

NYSE recorded the highest delisting with companies on the platform, dropping 15.28% year-over-year from 2,873 to 2,434. Elsewhere, Nasdaq listed companies grew 7.86% from 3,306 to 3,566. Data on the number of listed companies on NASDAQ and NYSE is provided by The World Federation of Exchanges.

The delisting of the companies is potentially guided by basic factors such as violating listing regulations and failing to meet minimum financial standards like the inability to maintain a minimum share price, financial ratios, and sales levels. Additionally, some companies might opt for voluntary delisting motivated by the desire to trade on other exchanges.

Furthermore, the delisting on U.S. major exchanges might be due to the emergence of new alternative markets, especially in Asia. China and Hong Kong markets have become more appealing, with regulators making local listings more attractive. Over the years, exchanges in the region have strived to emerge as key players amid dominance by U.S. equity markets. As per a previous report, the U.S. controls 56% of the global stock market value.

A significant portion of the delisted companies also stems from the regulatory perspective pitting U.S. agencies and their Chinese counterparts. For instance, China Mobile Ltd, China Unicom, and China Telecom Corp announced their delisting from NYSE, citing investment restrictions dating from 2020.

Worth noting is that the delisting of firms was initiated due to strict measures put in place by the Trump administration. The current administration has left the regulations in place while proposing additional regulations. For instance, a recent regulation update by the Securities Exchange Commission requiring US-listed Chinese companies to disclose their ownership structure has led to the exit of cab-hailing company Didi from the NYSE.

Impact of pandemic on the listing of companies

The delisting also comes in the wake of the Covid-19 pandemic that resulted in economic turmoil. With the shutdown of the economy, most companies entered into bankruptcies as the stock market crashed to historical lows.

Lower stock prices translate to less wealth for businesses, pension funds, and individual investors, and listed companies could not get the much-needed funding for their normal operations.

At the same time, the focus on more companies going public over the last year can be highlighted by firms on the Nasdaq exchange. Worth noting is that in 2020, there was tremendous growth in special purpose acquisition companies (SPACs), mainly driven by the impact of the coronavirus pandemic. With the uncertainty of raising money through the traditional means, SPACs found a perfect role to inject more funds into capital-starving companies to go public.

From the data, foreign companies listing in the United States have grown steadily, with the business aiming to leverage the benefits of operating in the country. Notably, listing on U.S. exchanges guarantees companies liquidity and high potential to raise capital. Furthermore, listing on either NYSE or Nasdaq comes with the needed credibility to attract more investors. The companies are generally viewed as a home for established, respected, and successful global companies.

In general, over the past year, factors like the pandemic have altered the face of stock exchanges to some point threatening the continued dominance of major U.S. exchanges. Tensions between the US and China are contributing to the crisis which will eventually impact the number of listed companies.


Courtesy of Finbold.

Read More

Continue Reading